Reflecting On Healthcare Technology Stocks’ Q2 Earnings: GoodRx (NASDAQ:GDRX)
1 Small-Cap Stock with Solid Fundamentals and 2 Facing Headwinds
GDRX Q2 Deep Dive: Pharma Direct and Subscription Growth Drive Upgraded Outlook
1 Stock Under $10 with Exciting Potential and 2 Facing Headwinds
GoodRx (NASDAQ:GDRX) Reports Upbeat Q2 CY2026, Stock Soars
Pharma Direct and Subscription Revenue Increased 76% and 39%, Respectively, Year-Over-Year Company Raises Full-Year 2026 Revenue and Adjusted EBITDA Expectations
Barchart Research What to Expect from GDRX Earnings GDRX Generated August 4, 2026 Current Price $3.33 EPS Estimate $$0.04 Consensus Rating Hold Average Move 8.65% GoodRx Prescription Savings Platform Shows...
GoodRx Earnings: What To Look For From GDRX
1 Cash-Producing Stock for Long-Term Investors and 2 We Avoid
GoodRx (GDRX): Buy, Sell, or Hold Post Q1 Earnings?